Regentis Biomaterials Patents Solvent-Free Process, Boosting Yield by 400%
Regentis Biomaterials has patented a new solvent-free manufacturing process for its GelrinC hydrogel, achieving a 400% increase in production yield. This innovation streamlines the production of the cartilage-repair biomaterial while enhancing its environmental and regulatory profile.